BR9914530A - Aplicação de composição oftálmica compreendendo vitamina a e vitamina e - Google Patents

Aplicação de composição oftálmica compreendendo vitamina a e vitamina e

Info

Publication number
BR9914530A
BR9914530A BR9914530-8A BR9914530A BR9914530A BR 9914530 A BR9914530 A BR 9914530A BR 9914530 A BR9914530 A BR 9914530A BR 9914530 A BR9914530 A BR 9914530A
Authority
BR
Brazil
Prior art keywords
vitamin
application
ophthalmic composition
eye
cocktail
Prior art date
Application number
BR9914530-8A
Other languages
English (en)
Inventor
Gyoergy Lajos Kis
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of BR9914530A publication Critical patent/BR9914530A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals

Abstract

Patente de Invenção: <B>"APLICAçãO DE COMPOSIçãO OFTáLMICA COMPREENDENDO VITAMINA A E VITAMINA E"<D>. A presente invenção refere-se ao uso de um coquetel de vitaminas compreendendo tanto vitamina A quanto vitamina E na preparação de um medicamento ocular para a proteção do olho contra tanto irradiação UV como ozónio.
BR9914530-8A 1998-10-14 1999-10-12 Aplicação de composição oftálmica compreendendo vitamina a e vitamina e BR9914530A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98811021 1998-10-14
PCT/EP1999/007626 WO2000021528A1 (en) 1998-10-14 1999-10-12 Use of ophthalmic composition comprising vitamin a and vitamin e

Publications (1)

Publication Number Publication Date
BR9914530A true BR9914530A (pt) 2001-06-26

Family

ID=8236382

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9914530-8A BR9914530A (pt) 1998-10-14 1999-10-12 Aplicação de composição oftálmica compreendendo vitamina a e vitamina e

Country Status (14)

Country Link
US (1) US6291519B1 (pt)
EP (1) EP1121120A1 (pt)
JP (1) JP2002527391A (pt)
KR (1) KR20010080136A (pt)
CN (1) CN1323207A (pt)
AR (1) AR020781A1 (pt)
AU (1) AU6338199A (pt)
BR (1) BR9914530A (pt)
CA (1) CA2346867A1 (pt)
HK (1) HK1040640A1 (pt)
IL (1) IL142385A0 (pt)
NO (1) NO20011694L (pt)
WO (1) WO2000021528A1 (pt)
ZA (1) ZA200102956B (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4849288B2 (ja) * 2000-09-29 2012-01-11 ライオン株式会社 点眼剤及び涙液膜の安定化剤
CA2492989C (en) * 2002-07-23 2012-11-20 Novartis Ag Ophthalmic ointment composition comprising a drug, an ointment base and a solubilizing/dispersing agent
JP4694773B2 (ja) * 2003-06-06 2011-06-08 ロート製薬株式会社 粘膜適用液状組成物
AU2005304822B2 (en) 2004-11-04 2008-10-16 Sirion Therapeutics, Inc. Modulators of retinol-retinol binding protein (RBP)-transthyretin (TTR) complex formation
WO2007070463A2 (en) * 2005-12-12 2007-06-21 Riolan Technologies, Inc. Compositions, methods and kits for removing debris from an ocular area
EP2043628A4 (en) * 2006-06-27 2009-11-25 Riolan Technologies Inc ULTRAVIOLET ABSORBENT OPHTHALMIC COMPOSITIONS
BR112012001998B8 (pt) * 2009-07-27 2021-05-25 Del Prete Antonio solução oftálmica, uso de um composto, e, método para preparação de uma solução oftálmica
JP5518608B2 (ja) * 2010-07-09 2014-06-11 ロート製薬株式会社 粘膜適用液状組成物
IT1401727B1 (it) * 2010-09-10 2013-08-02 Lab Farmaceutici Krymi S P A Maschera vinilica con effetto pee-off ad uso topico contenente alte concentrazioni di acido trans-retinoico o 13-cis
IT1407612B1 (it) * 2011-01-13 2014-04-30 Baif Internat Products New York S N C Composizioni oftalmiche per la nutrizione, il mantenimento dell'integrita' dell'epitelio dei tessuti oculari e la protezione degli stessi dall'ossidazione.
US10383839B2 (en) * 2011-06-30 2019-08-20 Johnson & Johnson Vision Care, Inc. Esters for treatment of ocular inflammatory conditions
JP2012006962A (ja) * 2011-08-22 2012-01-12 Lion Corp 眼科用組成物
JP2014089482A (ja) * 2014-02-18 2014-05-15 Lion Corp コンタクトレンズ装着液
US10413528B2 (en) * 2014-10-20 2019-09-17 John H. Plumb Methods to inhibit infection during wound healing with topical compositions including amino acids
JP7217082B2 (ja) * 2016-07-29 2023-02-02 ロート製薬株式会社 複合目症状改善用眼科組成物
KR102010047B1 (ko) 2017-07-18 2019-08-13 주식회사 포스코 선재가공장치 및 선재가공방법
KR102548710B1 (ko) * 2020-12-24 2023-06-28 주식회사 종근당 디쿠아포솔 또는 이의 약제학적으로 허용가능한 염과 토코페롤을 함유하는 건성안 예방 또는 치료용 약제학적 조성물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3416209A1 (de) 1984-05-02 1985-11-21 Mohamed Roshdy Dr Ismail Zubereitungen zur behandlung von augen
US5039513A (en) 1987-10-22 1991-08-13 The Procter & Gamble Company Photoprotection compositions and methods comprising sorbohydroxamic acid
US4999348A (en) 1987-12-11 1991-03-12 Estee Lauder Inc. Liquid crystal containing cosmetic and pharmaceutical compositions and methods for utilizing such compositions
US5002760A (en) 1989-10-02 1991-03-26 Katzev Phillip K Retinol skin care composition
JP3256997B2 (ja) 1990-08-30 2002-02-18 千寿製薬株式会社 安定な水性製剤
JP2636988B2 (ja) 1991-09-02 1997-08-06 大宝工業 株式会社 気体圧送金型
JP2939082B2 (ja) * 1993-02-23 1999-08-25 ライオン株式会社 安定なビタミンａパルミテート及びビタミンｅ類可溶化点眼剤
US5571503A (en) 1995-08-01 1996-11-05 Mausner; Jack Anti-pollution cosmetic composition
ATE302599T1 (de) 1996-05-24 2005-09-15 Angiotech Pharm Inc Zubereitungen und verfahren zur behandlung oder prävention von krankheiten der körperpassagewege
US6036946A (en) * 1997-12-24 2000-03-14 Shaklee Corporation Methods for protecting skin from damaging effects of ultraviolet light

Also Published As

Publication number Publication date
CA2346867A1 (en) 2000-04-20
NO20011694D0 (no) 2001-04-04
JP2002527391A (ja) 2002-08-27
WO2000021528A1 (en) 2000-04-20
AU6338199A (en) 2000-05-01
EP1121120A1 (en) 2001-08-08
AR020781A1 (es) 2002-05-29
KR20010080136A (ko) 2001-08-22
ZA200102956B (en) 2002-05-17
WO2000021528A8 (en) 2000-05-25
CN1323207A (zh) 2001-11-21
IL142385A0 (en) 2002-03-10
HK1040640A1 (zh) 2002-06-21
US6291519B1 (en) 2001-09-18
NO20011694L (no) 2001-05-23

Similar Documents

Publication Publication Date Title
BR9914530A (pt) Aplicação de composição oftálmica compreendendo vitamina a e vitamina e
EP0998925A4 (en) TOPICAL ADMINISTRATION COMPOSITIONS CONTAINING VITAMINS D AND VITAMINS K
BR0012445A (pt) Agentes com ação absorvente e/ou refletora de radiação uv para proteção contra radiação uv nociva à saúde e para reforçar a barreira natural da pele
BR0214264A (pt) Composição, processo de preparação da composição e seus usos
AU2001237433A1 (en) Preparation containing quinoxaline derivatives
BR0204979A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de tintura de oxidação, de tratamento e descoloração das fibras queratìnicas humanas, e uso de pelo menos um silicone aminado
BR9910113A (pt) Composições oftálmicas que se transformam em gel, contendo goma xantano
AR052921A1 (es) Uso de ranolazina para la preparacion de una composicion farmaceutica y composicion farmaceutica
FI956014A0 (fi) Nona- ja dekapeptidien käyttö lääkkeen valmistamiseksi AIDS-sairauden hoitoon
BR0111648A (pt) Compostos da famìlia das n-acilamino-amidas, composições que os contêm, usos e processo de tratamento cosmético
RU95105887A (ru) Косметические фильтрующие композиции и их применение
CA2293470A1 (en) Benzimidazole derivatives
ATE309798T1 (de) Pharmazeutische zusammensetzungen enthaltend cannabidiol-derivate
ATE293433T1 (de) Formulierungen mit antiviraler wirkung
BR0106913A (pt) Composições transparentes de limpeza em barra que são eficazes e não são irritantes para os olhos
GR3027749T3 (en) Cosmetic or pharmaceutical composition for topical application active against free radicals.
EP0868909A3 (en) Ophthalmic carrier solution
ES2192832T3 (es) Uso de compuestos macrolidos para tratar glaucoma.
BR0116251A (pt) composição de lágrimas artificiais contendo uma combinação de três demulcentes
BR9914128A (pt) Composições antibióticas para tratamento do olho, ouvido e nariz
BR0015392A (pt) Lipoxina a4 e seus análogos para o tratamento de olho ressecado
CA2345466A1 (en) Sustained release, and comfortable ophthalmic composition and method for ocular therapy
BR0204911A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de preparação de uma composição. processo e dispositivo com dois compartimentos ou &#39;kit&#39; para a descoloração ou a deformação permanente das fibras queratìnicas humanas
HUP0001268A2 (hu) Nátriumcsatorna-blokkoló alkalmazása glaukómával kapcsolatos szemideg-degenerálódás megelőzésére szolgáló gyógyászati készítmény előállítására
EP1417970B1 (en) Anti-allergic, anti-bacteric and anti-redden compound for eyes

Legal Events

Date Code Title Description
FA10 Dismissal: dismissal - article 33 of industrial property law
B11Y Definitive dismissal - extension of time limit for request of examination expired [chapter 11.1.1 patent gazette]